Barzilay E, Kessler D, Berlot G, Gullo A, Geber D, Ben Zeev I
Intensive Care Unit, Central Emek Hospital, Afula, Israel.
Crit Care Med. 1989 Jul;17(7):634-7. doi: 10.1097/00003246-198907000-00007.
We compared retrospectively four similar groups of patients with multiple organ failure (MOF) due to sepsis. All of them were treated initially with conventional therapy, aprotinin as protease inhibitor and vitamin C with allopurinol as possible scavengers of oxygen-free radicals, were also added. After 24 h of no clinical progress, continuous arteriovenous hemofiltration (CAVH), CAVH/dialysis (CAVH/D), and sequential plasmafilter-dialysis with slow continuous hemofiltration (CAVHP/D) were respectively added to groups 2 (n = 14), 3 (n = 6), and 4 (n = 11). Mortality was 87% for group 1, 71% for group 2, 50% for group 3, and 36% for group 4. In the latter we were able to remove possible MOF-inducing mediators from the bloodstream, to give fluids without restriction (even in oliguric patients), and to improve removal of metabolic waste products. It is possible that these extracorporeal supports, associated with conventional therapy, and pharmacologic drugs such as protease inhibitors and possible scavengers of oxygen-free radicals, helped to reduce the mortality rate. We conclude that, although the number of study patients was too small to reach firm conclusions, the good results observed with CAVHP/D suggest clinical trials to assess the efficacy of this technique.
我们回顾性比较了四组因脓毒症导致多器官功能衰竭(MOF)的相似患者。所有患者最初均接受常规治疗,还添加了作为蛋白酶抑制剂的抑肽酶以及作为可能的氧自由基清除剂的维生素C和别嘌呤醇。在24小时无临床进展后,分别对第2组(n = 14)、第3组(n = 6)和第4组(n = 11)添加持续动静脉血液滤过(CAVH)、CAVH/透析(CAVH/D)以及序贯血浆滤过 - 透析联合缓慢持续血液滤过(CAVHP/D)。第1组的死亡率为87%,第2组为71%,第3组为50%,第4组为36%。在第4组中,我们能够从血液中清除可能诱导MOF的介质,无限制地补液(即使是少尿患者),并改善代谢废物的清除。这些与常规治疗相关的体外支持措施以及诸如蛋白酶抑制剂和可能的氧自由基清除剂等药物可能有助于降低死亡率。我们得出结论,尽管研究患者数量太少无法得出确凿结论,但CAVHP/D观察到的良好结果提示应进行临床试验以评估该技术的疗效。